Baker Brothers Advisors - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 47 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$76,879,940
+4.4%
4,865,8190.0%0.44%
+4.0%
Q2 2023$73,668,500
+4.4%
4,865,8190.0%0.43%
+10.9%
Q1 2023$70,554,376
+7.2%
4,865,8190.0%0.38%
-2.8%
Q4 2022$65,785,873
-14.2%
4,865,8190.0%0.40%
-21.3%
Q3 2022$76,685,000
+29.4%
4,865,8190.0%0.50%
+49.4%
Q2 2022$59,266,000
+34.2%
4,865,819
+3.4%
0.34%
+32.3%
Q1 2022$44,174,000
-45.2%
4,704,4190.0%0.25%
-35.2%
Q4 2021$80,540,0004,704,4190.39%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders